NCT05736536 (BMI) is a NA clinical trial of Chance2Act in Obesity, sponsored by Universiti Teknologi Mara.

Who is sponsoring NCT05736536?

NCT05736536 is sponsored by Universiti Teknologi Mara.

What drugs are being tested in NCT05736536?

Interventions in NCT05736536: Chance2Act.

What condition does NCT05736536 study?

NCT05736536 studies Obesity, Diabetes Mellitus, Type 2, Behavior.

Is NCT05736536 still recruiting?

NCT05736536 is currently completed. Last updated 1 February 2024.

Last reviewed 2024-02-01 · How we verify

NCT05736536: BMI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behavior Intervention for Weight Loss for Type 2 Diabetes Mellitus Adults With Obesity Problem (BMI of ≥23kg/m2)

Completed NA Last updated 1 February 2024

What this trial tests

NA trial testing Chance2Act in Obesity in 104 participants. Completed in 15 December 2023.

Timeline

1 April 2023

Primary endpoint
15 December 2023

15 December 2023

Quick facts

Lead sponsor	Universiti Teknologi Mara
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	104
Start date	1 April 2023
Primary completion	15 December 2023
Estimated completion	15 December 2023
Sites	2 locations across Malaysia

Drugs / interventions tested

Chance2Act

Conditions studied

Obesity — all drugs for Obesity →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Behavior — all drugs for Behavior →

Sponsor

Universiti Teknologi Mara

Who can join

Adults 20 to 65, any sex, with Obesity or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This quasi-experimental study aims to determine the effectiveness of a health intervention (Chance2Act) on behaviour change to act for weight loss among overweight/obese type 2 diabetes adults. The main question it aims to answer is: \- Is the new health intervention (Chance2Act) effective in changing overweight/obese type 2 diabetes adults from not being ready to act, to take action to lose weight?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Web-Based Intervention to Act for Weight Loss in Adults With Type 2 Diabetes With Obesity (Chance2Act): Protocol for a Nonrandomized Controlled Trial.
Mohd Saad N, Mohamad M, Mat Ruzlin AN. · · 2024 · cited 3× · PMID 38294848 · DOI 10.2196/48313

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Universiti Teknologi Mara trials

Trials by the same sponsor.

NCT07212894 — DemensiaKITA Mobile Health App to Improve Knowledge, Attitude, Practice and Reduce Burden Among Dementia Caregivers in M · NA · recruiting
NCT06993298 — ARPE Training for Manual Handling Workers: A Quasi-Experimental Study on Ergonomic Knowledge and Practice · NA · not yet recruiting
NCT07134010 — The Impact of Perineural Injection Therapy for Adhesive Capsulitis. · NA · recruiting
NCT07402967 — Perceptions of Parents and Children on Posterior Restorations in Primary Molars · completed
NCT06599645 — Impact of Combined CST, BFR, and Tai Chi on Muscle Physiology and Functional Characteristics Among Adults With LBP · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05736536 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiti Teknologi Mara
Last refreshed: 1 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05736536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing